Scientific communications services built for life sciences and biopharma programs. From your launch narrative to publication strategy to HCP education, led by a PhD scientist who understands your data.
Project-based engagement. Scoped to your program.
The scientific narrative foundation every life sciences program needs before its first major data disclosure. We architect your story from first principles, building MOA explanations, disease state narratives, and KOL-ready presentations that are both scientifically defensible and compellingly told.
This is not a templated deliverable. Every BioContent Launch Pack begins with our APC framework: we define who needs to understand your biology, at what depth, and in what format, before a single word is written.
A master narrative document defining how your MOA, disease state, and differentiation story are told across every channel.
Dual-version disease state document, one calibrated for investors and one for HCP audiences, with scientifically accurate biological context.
A detailed script for your mechanism of action animation or diagram, accurate enough for medical affairs and clear enough for a non-specialist investor.
A 3 to 5 page pipeline document covering indication, patient population, clinical rationale, trial design overview, and competitive context.
A 10 to 15 slide scientific presentation built for advisory boards, medical affairs meetings, and scientific partnership conversations.
Series A and B programs preparing for their first major data disclosure, partnership conversations, or investor roadshow.
Building the scientific narrative before clinical data exists, anchored in mechanistic and translational science.
Investor-ready materials that convey the biology opportunity accurately, without oversimplifying the science.
KOL and pharma partner-facing content that positions your program with scientific credibility and commercial clarity.
Typical timeline: 6 to 8 weeks from kickoff to final deliverables
The congress and publication calendar is unforgiving. A dedicated NoveraMed writer embedded in your program means you are always submission-ready.
AACR, ASCO, ASH, ESMO, SITC, AAI. We know the deadlines, the formats, and what reviewers are looking for.
Journal of Immunology, Cancer Immunology Research, Nature Immunology, JCI. Manuscript development calibrated to journal scope and reviewer expectations.
Phase 1 read-outs, investor days, and medical conference presentations with coordinated communication strategy across all channels.
Monthly retainer, minimum 3-month engagement
Monthly retainer. Minimum three-month commitment.
A dedicated scientific writer embedded in your program, managing the full publication and congress pipeline. No more scrambling before abstract deadlines or losing manuscript momentum between experiments.
Full-service manuscript writing, coauthor coordination, response to reviewer, and submission management across target journals.
Congress-format abstracts, scientific posters, and oral presentation scripts built on the same scientific narrative foundation across every meeting.
Speaker preparation, talking point documents, Q&A preparation for medical affairs, and congress booth content.
Recaps, KOL quotes, investor updates, and digital content extending your congress presence beyond the meeting itself.
Setup phase, then ongoing retainer. Scoped to your program stage.
As your program moves toward Phase 2 and beyond, the physicians who will prescribe and the patients who will benefit need to be educated. HCP education platforms, MSL field force materials, and patient-facing disease awareness content, all anchored in the same scientifically accurate narrative.
Disease education modules, MOA deep-dives, clinical evidence summaries, and treatment algorithm content for HCP-facing digital platforms.
Scientific exchange materials, reactive reference documents, and clinical evidence packages for medical science liaison teams engaging with specialist KOLs.
Patient-facing disease state education, clinical trial awareness materials, and caregiver resources, developed with appropriate lay language and regulatory compliance.
Speaker slide decks, program faculty materials, and training content for KOL speaker bureau programs.
When your program reaches Phase 2, the scientific communications challenge shifts. It is no longer only about telling investors your story. It is about educating the physicians who will ultimately use your therapy.
Oncologists, immunologists, and disease-area specialists need different content than general practitioners. We write for your actual prescriber audience.
All HCP and patient materials are developed with regulatory compliance as a foundational requirement, not a final review step.
Every HCP and patient piece draws from the same scientific narrative established in your BioContent Launch Pack, ensuring total consistency across channels.
Setup phase: 8 to 12 weeks, then ongoing retainer
Our services are scoped to your program stage. Most clients begin with the BioContent Launch Pack and add a Publication retainer as their data matures.
Your scientific narrative foundation
Scoped to your program stage and deliverables
Dedicated writer embedded in your program
Minimum 3-month commitment
For Phase 2 programs and beyond
Scoped to your program. Setup phase, then ongoing.
To maintain the depth of scientific engagement our clients expect, NoveraMed partners with a select number of life sciences programs at any given time. We work best with Series A through C biotechs with complex biology programs requiring genuine scientific literacy in their communications team.
Currently accepting applications for Q2 and Q3 2026 partnerships.
Tell us about your program and we will tell you which NoveraMed service makes the most sense for your current stage.
Schedule a Consultation